Experimental studies with MPO knockout mice or oral MPO inhibitors showed reduced left ventricle dilation and improved left ventricular function in myocardial infarction models, indicating MPO's role in developing chronic heart failure [115]. The gene discussed is MPO; the disease is congestive heart failure.